Market Analysis and Price Projections for the Drug NDC: 00574-1104
Overview of the Drug
The drug with the NDC code 00574-1104 is a syrup formulation of Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide. This combination is commonly used to treat symptoms of the common cold, such as congestion, cough, and sneezing[5].
Active Ingredients and Dosage
Each 5 mL (1 teaspoonful) of the syrup contains:
- Brompheniramine Maleate: 2 mg
- Pseudoephedrine Hydrochloride: 30 mg
- Dextromethorphan Hydrobromide: 10 mg
This formulation is available in various package sizes, including 4 fl oz (118 mL) and 1 pint (473 mL)[5].
Market Trends and Pricing
Current Pricing
As of the latest data available in December 2024, the price per unit for this drug varies slightly depending on the package size and the vendor. Here are some current prices:
- BROMPHEN-PSE-DM 2-30-10 MG/5 ML, NDC 00574-1104-04: Approximately $0.09309 per mL[1].
- BROMPHEN-PSE-DM 2-30-10 MG/5 ML, NDC 00574-1104-16: Approximately $0.09227 per mL[1].
Historical Price Trends
Historical data shows that the prices of this drug have remained relatively stable over the past few months. For instance, the price per unit for the 4 fl oz package has fluctuated between $0.09227 and $0.09309 per mL from October 2024 to December 2024[1].
Factors Influencing Pricing
Several factors can influence the pricing of this drug:
- Competition from Generic Drugs: The presence of generic versions of this drug can drive prices down due to increased competition[3].
- Regulatory and Reimbursement Policies: Changes in regulatory policies and reimbursement rates can significantly impact the pricing strategy of pharmaceutical companies[3].
- Supply Chain Dynamics: Fluctuations in the cost of raw materials and manufacturing can also affect the final price of the drug.
Market Analysis
Demand and Supply
The demand for over-the-counter (OTC) cold and cough medications remains consistent, driven by the common occurrence of cold and flu seasons. However, the supply side is influenced by factors such as production costs, regulatory approvals, and competition from other OTC medications.
Competitive Landscape
The market for cold and cough medications is highly competitive, with numerous brands and generic options available. Companies like Padagis US LLC, which packages the NDC 00574-1104, must navigate this competitive landscape by ensuring competitive pricing, quality, and marketing strategies.
Regulatory Environment
The regulatory environment plays a crucial role in the pricing and availability of pharmaceuticals. For example, changes in FDA regulations or reimbursement policies under Medicare and Medicaid can impact the pricing and profitability of drugs like BROMPHEN-PSE-DM[3].
Price Projections
Short-Term Projections
Given the stable historical price trends, it is likely that the prices for BROMPHEN-PSE-DM will remain relatively stable in the short term, fluctuating within the current range of $0.09227 to $0.09309 per mL.
Long-Term Projections
In the long term, several factors could influence price projections:
- Generic Competition: As patents expire, generic versions may enter the market, potentially driving prices down[3].
- Inflation and Economic Factors: General inflation and economic conditions can affect the cost of production and, subsequently, the retail price of the drug.
- Technological and Innovational Advances: Advances in digital transformation and innovative therapies might lead to new market dynamics, but these are less likely to directly impact the pricing of established OTC medications like BROMPHEN-PSE-DM[3].
Conclusion
The market analysis for the drug NDC 00574-1104 indicates a stable pricing environment in the short term, with potential long-term influences from generic competition, regulatory changes, and broader economic factors.
Key Takeaways
- Current Pricing: The drug is priced around $0.09227 to $0.09309 per mL.
- Historical Trends: Prices have been relatively stable over recent months.
- Market Factors: Competition from generics, regulatory policies, and supply chain dynamics can influence pricing.
- Long-Term Projections: Prices may be affected by generic competition, inflation, and economic factors.
FAQs
What are the active ingredients in the drug NDC 00574-1104?
The active ingredients are Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide.
What are the common uses of this drug?
This drug is commonly used to treat symptoms of the common cold, such as congestion, cough, and sneezing.
How does the price of this drug compare to other similar medications?
The price of BROMPHEN-PSE-DM is competitive within the market for OTC cold and cough medications, with prices fluctuating slightly based on package size and vendor.
What factors could lead to changes in the price of this drug in the future?
Factors such as generic competition, regulatory changes, and broader economic conditions could influence future pricing.
Where can I find more detailed pricing data for this drug?
Detailed pricing data can be found through resources like DrugPatentWatch and NADAC pricing data[1][4].
Sources
- DrugPatentWatch - Drug prices and trends for BROMPHEN-PSE-DM
- DrugPatentWatch - Latest drug prices and trends for NDC 51672-1387
- Deloitte Insights - 2025 life sciences outlook
- NADAC - Drug Pricing Brompheniramine Maleate, Pseudoephedrine ...
- DailyMed - BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE syrup
